Literature DB >> 21624367

p53 regulation by ubiquitin.

Christopher L Brooks1, Wei Gu.   

Abstract

The ubiquitination pathway is a highly dynamic and coordinated process that regulates degradation as well as numerous processes of proteins within a cell. The p53 tumor suppressor and several factors in the pathway are regulated by ubiquitin as well as ubiquitin-like proteins. These modifications are critical for the function of p53 and control both the degradation of the protein as well as localization and activity. Importantly, more recent studies have identified deubiquitination enzymes that can specifically remove ubiquitin moieties from p53 or other factors in the pathway, and the reversible nature of this process adds yet another layer of regulatory control of p53. This review highlights the recent advances in our knowledge of ubiquitin and the p53 pathway.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21624367      PMCID: PMC3172401          DOI: 10.1016/j.febslet.2011.05.022

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  95 in total

1.  Excess HDM2 impacts cell cycle and apoptosis and has a selective effect on p53-dependent transcription.

Authors:  Shuichi Ohkubo; Tomoaki Tanaka; Yoichi Taya; Kenji Kitazato; Carol Prives
Journal:  J Biol Chem       Date:  2006-04-19       Impact factor: 5.157

2.  E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation.

Authors:  Laurent Le Cam; Laëtitia K Linares; Conception Paul; Eric Julien; Matthieu Lacroix; Elodie Hatchi; Robinson Triboulet; Guillaume Bossis; Ayelet Shmueli; Manuel S Rodriguez; Olivier Coux; Claude Sardet
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

3.  FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP.

Authors:  Armando van der Horst; Alida M M de Vries-Smits; Arjan B Brenkman; Miranda H van Triest; Niels van den Broek; Frédéric Colland; Madelon M Maurice; Boudewijn M T Burgering
Journal:  Nat Cell Biol       Date:  2006-09-10       Impact factor: 28.824

Review 4.  Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4.

Authors:  J-C Marine; S Francoz; M Maetens; G Wahl; F Toledo; G Lozano
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

Review 5.  Mouse bites dogma: how mouse models are changing our views of how P53 is regulated in vivo.

Authors:  G M Wahl
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

6.  WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization.

Authors:  York Tomita; Natasha Marchenko; Susan Erster; Alice Nemajerova; Alexander Dehner; Christian Klein; Hongguang Pan; Horst Kessler; Petr Pancoska; Ute M Moll
Journal:  J Biol Chem       Date:  2006-01-26       Impact factor: 5.157

7.  Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo.

Authors:  Ingo Ringshausen; Clodagh C O'Shea; Andrew J Finch; Lamorna Brown Swigart; Gerard I Evan
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

8.  Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes.

Authors:  Birgit Heltweg; Tonibelle Gatbonton; Aaron D Schuler; Jeff Posakony; Hongzhe Li; Sondra Goehle; Ramya Kollipara; Ronald A Depinho; Yansong Gu; Julian A Simon; Antonio Bedalov
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

9.  Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo.

Authors:  Sarah Francoz; Pascal Froment; Sven Bogaerts; Sarah De Clercq; Marion Maetens; Gilles Doumont; Eric Bellefroid; Jean-Christophe Marine
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

10.  The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis.

Authors:  Oliver Bischof; Klaus Schwamborn; Nadine Martin; Andreas Werner; Claudio Sustmann; Rudolf Grosschedl; Anne Dejean
Journal:  Mol Cell       Date:  2006-06-23       Impact factor: 17.970

View more
  89 in total

1.  Involvement of phosphoinositide 3-kinase and PTEN protein in mechanism of activation of TRPC6 protein in vascular smooth muscle cells.

Authors:  Michaël Monet; Nancy Francoeur; Guylain Boulay
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

2.  Extensive post-translational modification of active and inactivated forms of endogenous p53.

Authors:  Caroline J DeHart; Jasdave S Chahal; S J Flint; David H Perlman
Journal:  Mol Cell Proteomics       Date:  2013-09-20       Impact factor: 5.911

3.  The Drosophila ubiquitin-specific protease Puffyeye regulates dMyc-mediated growth.

Authors:  Ling Li; Sarah Anderson; Julie Secombe; Robert N Eisenman
Journal:  Development       Date:  2013-10-30       Impact factor: 6.868

4.  NUMB phosphorylation destabilizes p53 and promotes self-renewal of tumor-initiating cells by a NANOG-dependent mechanism in liver cancer.

Authors:  Hifzur R Siddique; Douglas E Feldman; Chia-Lin Chen; Vasu Punj; Hiroshi Tokumitsu; Keigo Machida
Journal:  Hepatology       Date:  2015-08-28       Impact factor: 17.425

5.  TSLP induces mast cell development and aggravates allergic reactions through the activation of MDM2 and STAT6.

Authors:  Na-Ra Han; Hyun-A Oh; Sun-Young Nam; Phil-Dong Moon; Do-Won Kim; Hyung-Min Kim; Hyun-Ja Jeong
Journal:  J Invest Dermatol       Date:  2014-04-21       Impact factor: 8.551

6.  Impact of the adenoviral E4 Orf3 protein on the activity and posttranslational modification of p53.

Authors:  Caroline J DeHart; David H Perlman; S J Flint
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

Review 7.  Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives.

Authors:  Mir Mohd Faheem; Nathan D Seligson; Syed Mudabir Ahmad; Reyaz Ur Rasool; Sumit G Gandhi; Madhulika Bhagat; Anindya Goswami
Journal:  Cell Death Discov       Date:  2020-06-15

8.  A nuclear phosphoinositide kinase complex regulates p53.

Authors:  Suyong Choi; Mo Chen; Vincent L Cryns; Richard A Anderson
Journal:  Nat Cell Biol       Date:  2019-03-18       Impact factor: 28.824

Review 9.  Role of deubiquitinases in DNA damage response.

Authors:  John Le; Eric Perez; Leah Nemzow; Feng Gong
Journal:  DNA Repair (Amst)       Date:  2019-02-21

Review 10.  The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

Authors:  Oleg Laptenko; David R Tong; James Manfredi; Carol Prives
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.